Laura L. Quinn

Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy

Joseph P. Sanderson, Darragh Crowley, Guy E. Wiedermann et al. · OncoImmunology · 2019 · 96 citations · Full text

Life Sciences, Immunology, Oncology +17

The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways

Jianmin Zuo, Laura L. Quinn, Jennifer Tamblyn et al. · Journal of Virology · 2010 · 95 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II

Laura L. Quinn, Luke Williams, Claire White et al. · Journal of Virology · 2015 · 91 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition

Heather M. Long, Alison M. Leese, Odette Chagoury et al. · The Journal of Immunology · 2011 · 76 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle

Laura L. Quinn, Jianmin Zuo, Rachel J.M. Abbott et al. · PLoS Pathogens · 2014 · 66 citations · Full text

Life Sciences, Immunology, Molecular Biology +17